Who invested in SerlImmune?
SerlImmune's investors include Merck Global Health Innovation Fund and Illumina Ventures.
United States · Funded startup
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$8.0Mraised across 1 round since 2017, from 1 source
SerlImmune's investors include Merck Global Health Innovation Fund and Illumina Ventures.
SerlImmune has raised $8.0M across 1 round since 2017.
SerlImmune's most recent round was an Undisclosed round of $8.0M in Jun 2017.
Its most recent round, $8.0M in Jun 2017, is also its largest on record.
SerlImmune's first round on record, in Jun 2017, was backed by Merck Global Health Innovation Fund and Illumina Ventures.
SerlImmune's latest named round is an Undisclosed round, in Jun 2017.
SerlImmune is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.